and launch. are Thanks four PDUFA The date from exactly Jon. we is ready weeks to today ORLADEYO
years ago. launch would invested to success. critical of knew demographics be a understanding needs We this that We access deep investing customers are attitudes, our because started we and because of early, ready, in we the
to in more execute an investments early key is each We also invested I'll team experienced to that describe these build ready plan. of detail. our
all patients sample in XX% that our treats over how will of respond that's of view HAE surveyed we When patient we a When large behaviors, surveys physician clear to attitudes customers. unbiased physicians, did future for we and example, understand and customers didn't research ORLADEYO. conducted invested gain XXX we the treating First, in X,XXX HAE and to patients cut very and corners. We prescriber HAE market patient to U.S. understanding our a
in very treatment This APeX-S we switching this injectable still patients administration the treating detract satisfied their Here's more seen because half told because ORLADEYO. the say normal are targeted that and They injectable to want see U.S. live us want want from Haegarda more what that oral Patients to switch you needle treatment. big with XX% the in change and starting an therapies, why clear exist, for preparation data cope how more. the on these with explains the HAE preferences, tell physicians their Takhzyro, and that or next once-daily injectable patients evolution of and a time, who such surveyed, on the consistently the of from enrolling their We've think treatments in movement all are the thing are grateful of therapy burden they injections, Patients they the lives. comprehensive freedom they to as something their limit already research all ability and for tells difficulties are they to HAE but of having Cinryze. physicians burdens fatigue, as natural oral us. therapy. about nothing. option Megan remember opportunity how patient treatment, Patients about as new will
As part the off in HAE. shelf customer for are providers market treat there understanding In solutions rare our of of the healthcare who targeting. no invested preparation, universe diseases, we also
data. pharmacy traditional get can't prescription You
and we Orladeyo, with go now, team We're into to also with data understanding And XX their payers interviews did over time our cover list data since right with layered we the on oral from an XX completed sales list reps want how in with premium they pay that a therapy at treater to process XXX consistent. understand customer our them back XXX what that million are build how HAE customers patients, pay the important services year feedback covered highlight lives. are million engaging tell We great use in So our for negative. them. payers to to we smooth HAE is it. ways how representing ago, are they qualitative HAE to to July. and sales payers and invested products will covered quantitative the patient help customer A don't then of Payer represent Takhzyro costs over it set $XXX,XXX target by visits target like us, team positive taking for our year. invested deeper outreach. access value deliver cover making will even goal, less more best-in-industry to out I'd lives. we but we we itself. care process. have will treaters And priced with work travel over but through past They that Orladeyo for sources, these two over and the their There Orladeyo, refine injectable and and the to team several on profiling that customers a structure What like Equally future is is they started has been if hear additional They several to important per to $XXX,XXX build years, both program recognize access therapies XX Haegarda experiences we that our components. We database. will
of during repeatedly coordinator. to a every about patients process. frustration care providers The will first access the have dedicated that health person practice the and person patients their being from and inefficiencies heard with care We their from transferred is
value their also about between heard patient the long-term service relationships We of patients. programs and
healthcare and the process, ongoing build and streamline to coordinate ready patients are shipments both to coordinators access product patients relationships with providers. dedicated Our
component closely patient our patient second to The with services we field that, is support are Orladeyo access. teams linking
patient to execute. access ready XXX practices. HAE with We've in assist market And to is payer and to built access field finally, coordinators authorizations, people. treating Our in knows team And U.S. has our commercial that with other education, we built team to a relationships Orladeyo. reimbursement speed team already the steps top how invested prior
Each XX record including sales oncology, has years years one XX products BioCryst. gene a track the commercial Orladeyo passion launch part patients. launching as them disease. BioCryst, a of understand team bring hired growth to want therapy, as to in They and that will They disease value for they rare of previous joined of team and of industry have experience, transformation in leadership a the that because HAE rare nearly Our well they of launches. success averages be
pay to about off, the because is are ready. investments Our team
day ready to Orladeyo the approved. We is launch are
ready, a We're ready, have therapy. this because been because oral for market. invested we HAE that targeted patients waiting understanding years We know are in we've
We are ready, because wait to we longer. don't any want patients
over Megan describe the to team's our to call I'll turn medical preparations. Now,
